证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-049 宁波杉杉股份有限公司 关于控股股东及其全资子公司实质合并重整案 第二次债权人会议表决结果的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波杉杉股份有限公司（下称"公司"）的控股股东杉杉集团有限公司（下 称"杉杉集团"）及其全资子公司宁波朋泽贸易有限公司（下称"朋泽贸易"）于 2025 年 3 月 20 日被浙江省宁波市鄞州区人民法院裁定进行实质合并重整。 近日，公司收到杉杉集团及朋泽贸易重整管理人（下称"管理人"）的通知， 2025 年 5 月 30 日 17 时至 2025 年 6 月 5 日 17 时，杉杉集团和朋泽贸易合并破 产重整案第二次债权人会议（下称"本次会议"）以书面会议形式通过"破栗子- 破产案件一体化管理平台"会议系统召开。本次会议中的《关于意向投资人招募 的公告》的表决期于 2025 年 6 月 5 日 17:00 届满。现将本次会议表决结果公告 如下： 一、《关于意向投资人招募的公告》表决情况 公司郑重提醒广大投资者，公 ...

证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-048 宁波杉杉股份有限公司 关于控股股东重整的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波杉杉股份有限公司（下称"公司"）的控股股东杉杉集团有限公司（下 称"杉杉集团"）及其全资子公司宁波朋泽贸易有限公司（下称"朋泽贸易"）于 杉杉集团在上海证券交易所网站发布的相关公告，现将相关情况公告如下： 目前，公司控股股东不存在非经营性资金占用、违规担保等侵害上市公司利 益的情形。公司具有独立完整的业务及自主经营能力，公司与控股股东在资产、 业务、财务等方面均保持独立。目前公司生产经营一切正常，本次事项目前未对 公司日常生产经营造成重大实质影响，后续公司将持续努力做好各项经营管理工 作，以保障上市公司稳健经营。 截至 2025 年 5 月 31 日，杉杉集团持有公司股份 320,296,700 股，占公司总 股本的 14.24%；朋泽贸易持有公司股份 205,264,756 股，占公司总股本的 9.13%。 前述所持公司股份存在较高比例被质押、司法冻 ...

证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-047 宁波杉杉股份有限公司 一、 担保情况概述 关于2025年5月份提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 （一）担保基本情况 司同意为下属子公司提供如下担保： 宁波分行申请不超过11,800万元人民币的综合授信额度。公司同意就上述申请授 信事项提供不超过11,800万元人民币的连带责任保证担保。 办理融资租赁业务并签订《融资租赁合同》。公司为上述事项提供连带责任保证 担保，担保金额为64,818.14万元人民币，详见公司于2023年6月2日在上海证券 交易所网站发布的相关公告。 意为该《融资租赁合同》项下四川杉杉新材料有限公司所负全部债务提供不可撤 销的全额连带责任保证担保，担保金额为64,818.14万元人民币。 （二）履行的内部决策程序 ● 被担保人名称及是否为上市公司关联人： 上海杉杉锂电材料科技有限公司下属全资子公司宁波杉杉新材料科技有限公 司、四川杉杉新材料有限公司，为宁波杉杉股份有限公司（下称"公司"） 合 ...

宁波杉杉股份有限公司 证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-047 关于2025年5月份提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 ● 被担保人名称及是否为上市公司关联人： 上海杉杉锂电材料科技有限公司下属全资子公司宁波杉杉新材料科技有限公 司、四川杉杉新材料有限公司，为宁波杉杉股份有限公司（下称"公司"） 合并报表范围内公司。本次担保不属于关联担保。 ● 本次担保金额及已实际为其提供的担保金额：本次提供的担保金额为 76,618.14万元人民币。本次担保前，公司及下属子公司已实际为其提供的担 保金额为771,794.36万元人民币。 ● 本次是否有反担保：无。 一、担保情况概述 （一）担保基本情况 | 担保方 | 被担保人 | 担保额度 | | 已提供的担保总额（万元人民币） | | | --- | --- | --- | --- | --- | --- | | | | | | 本次担保前 | 本次担保后 | | 宁波杉杉股份有 限公司 | | 不 超 过 亿元 ...

更多内容请查阅杉杉集团于 2025 年 5 月 13 日、2025 年 5 月 19 日、2025 年 6 月 3 日在上海证券交易所网站发布的公告全文。 证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-048 宁波杉杉股份有限公司 关于控股股东重整的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波杉杉股份有限公司（下称"公司"）的控股股东杉杉集团有限公司（下 称"杉杉集团"）及其全资子公司宁波朋泽贸易有限公司（下称"朋泽贸易"）于 2025 年 3 月 20 日被浙江省宁波市鄞州区人民法院裁定进行实质合并重整。根据 杉杉集团在上海证券交易所网站发布的相关公告，现将相关情况公告如下： 一、控股股东重整进展情况 1、根据杉杉集团发布的《杉杉集团有限公司关于公司及全资子公司实质合 并重整案召开第一次债权人会议的公告》《杉杉集团有限公司关于公司及全资子 公司实质合并重整案第一次债权人会议表决结果的公告》，2025 年 5 月 15 日 14 时 30 分，杉杉集团召开第一次债权人会议（下称"本次会议 ...

Core Viewpoint - The traditional perception of outlet malls as mere discount centers is evolving, with leading brands undergoing significant transformations to enhance their value proposition and customer experience [1][24]. Group 1: Industry and Brand Adjustments - Outlet malls are shifting from a focus on quantity to quality, emphasizing the introduction of new brands and enhancing the "first store concentration" metric [2][17]. - Major operators like Bailian and Shanshan are actively introducing new stores, with Bailian's Shanghai Qingpu outlet planning to add around 14 new stores in the first five months of 2024 [2][18]. - The introduction of mainstream luxury brands remains crucial for maintaining the appeal of outlet malls, with new stores from brands like Valentino and TORY BURCH being added [3][18]. Group 2: Sports and Outdoor Brands - The rise of urban sports lifestyles has led to an increased focus on sports and outdoor brands within outlet malls, with new entries from niche brands like CHUMS and BURTON [6][7]. - The strategy includes attracting unique and trendy brands to differentiate from competitors, enhancing the overall shopping experience [7][9]. Group 3: Dining Experience Enhancement - Outlet malls are moving away from being perceived as "dining deserts" by significantly increasing the number of dining options, with 3906 restaurant brands across 226 outlet projects by the end of 2024 [10][11]. - The top three projects in terms of dining options include Suzhou Kunshan Huqiao World City with 86 dining outlets, followed by Shanshan (Changsha) Outlet and Jinan First Creation Outlet [13][14]. Group 4: Space and Hardware Adjustments - A new wave of hardware upgrades is underway, with several outlet projects expanding their physical space to enhance customer experience and operational efficiency [26][30]. - Notable expansions include the Shanghai Qingpu Bailian Outlet, which plans to add around 100 new shops, potentially becoming the largest outlet in Asia [29][30]. - Projects are also focusing on fine-tuning existing spaces to create a more engaging shopping environment, as seen in the renovations at Zhengzhou Shanshan Outlet [34][36]. Group 5: Emotional Value and Cultural Integration - The evolution of outlet malls is marked by a shift from discount-driven shopping to creating emotional value and unique experiences for consumers [40][41]. - There is a growing emphasis on integrating local culture into the design and operation of outlet malls, fostering deeper connections with local consumers [41][42].

本次被司法处置的股份为宁波杉杉股份有限公司（下称"公司"）间接控 股股东杉杉控股有限公司（下称"杉杉控股"）持有的公司无限售流通股 22,159,786 股 ， 占 其 持 有 公 司 股 份 总 数 的 30.69% ， 占 公 司 当 前 总 股 本 （2,249,412,863 股）的 0.99%。 本次被司法处置的股份已全部竞买成交，后续尚涉及缴款、股权变更过 户等环节，其最终结果尚存在不确定性。公司将持续关注上述事项的进展，严格 按照相关法律、法规及规范性文件的要求及时履行信息披露义务，敬请广大投资 者理性投资，注意投资风险。 证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-046 宁波杉杉股份有限公司 关于间接控股股东部分持股被司法处置的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司于 2025 年 4 月 26 日披露了《关于间接控股股东部分持股将被司法处置 的提示性公告》（公告编号：临 2025-038），上海金融法院将于 2025 年 5 月 27 日在上海 ...

Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

Core Viewpoint - In 2024, despite challenges in the negative electrode materials and polarizer industries, the company achieved stable growth in its two main businesses, driven by strategic focus and continuous innovation [1][2]. Financial Performance - In 2024, the company reported total revenue of 186.36 billion yuan, with a net profit of 6.59 billion yuan from its core businesses, despite an overall net loss of 3.67 billion yuan due to losses from associated companies and non-core asset impairments [2][4]. - In Q1 2025, the company achieved revenue of 48.04 billion yuan, a year-on-year increase of 28.04%, and returned to profitability with a net profit of 0.33 billion yuan [1][5]. Business Segments - The negative electrode materials segment saw a revenue increase of 12.80% in 2024, with sales volume growing by 28.44%, maintaining a leading market position globally [1][2]. - The polarizer segment benefited from a recovery in the display panel industry, with a significant increase in demand driven by major international events, leading to a stable growth in sales [3][4]. - The company maintained a global market share of approximately 33% in large-size polarizers, ranking first in the market for LCD television and monitor polarizers [3][4]. Industry Trends - The demand for negative electrode materials is expected to continue rising due to increased penetration of electric vehicles and high growth in energy storage needs, although the industry faces challenges such as overcapacity and price declines [2][5]. - The polarizer market is experiencing a recovery, with predictions of sustained growth in demand, particularly in OLED and large-size displays [5].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600884 证券简称：杉杉股份 公告编号：临 2025-044 宁波杉杉股份有限公司 关于间接控股股东部分持股将被司法处置的提示性公告 重要内容提示： 本次将被司法处置的股份为宁波杉杉股份有限公司（下称"公司"）间接 控股股东杉杉控股有限公司（下称"杉杉控股"）持有的公司无限售流通股 13,000,000 股，占其持有公司股份总数的 18.00%，占公司总股本的 0.58%。 本次司法处置事项尚在公示阶段，后续将可能涉及竞拍、缴款、股权变 更过户等环节，司法处置结果尚存在不确定性。公司将持续关注上述事项的进展， 严格按照相关法律、法规及规范性文件的要求及时履行信息披露义务，敬请广大 投资者理性投资，注意投资风险。 近日，经公司网络查询并与杉杉控股核实，获悉上海金融法院在上海证券交 易所大宗股票司法协助执行平台（下称"司法执行平台"）发布了《司法处置股 票公告》（（2025）沪 74 执 511 号），该公告显示，上海金融法院将于 2025 年 6 月24日在司法执行平 ...